A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia

Leukemia ◽  
2015 ◽  
Vol 29 (6) ◽  
pp. 1312-1319 ◽  
Author(s):  
A K Burnett ◽  
N Russell ◽  
R K Hills ◽  
N Panoskaltsis ◽  
A Khwaja ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Nucleoside Analogue ◽  
Older Patients ◽  
Low Dose ◽  
The Novel ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

VERY-LOW-DOSE CYTARABINE FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKAEMIA IN THE ELDERLY

The Lancet ◽  
1986 ◽  
Vol 327 (8487) ◽  
pp. 966 ◽  
Author(s):  
Alison Worsley ◽  
G.J. Mufti ◽  
J.A. Copplestone ◽  
D.G. Oscier ◽  
T.J. Hamblin
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Myelodysplastic Syndromes ◽  
Low Dose ◽  
The Elderly ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

Low dose cytarabine monotherapy for acute myeloid leukaemia

2011 ◽  
Author(s):  
Kathrin Bauer ◽  
Franz Hutzschenreuter ◽  
Ina Monsef ◽  
Nicole Skoetz ◽  
Karl-Anton Kreuzer ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Low Dose ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

Low-dose cytarabine for acute myeloid leukaemia and myelodysplastic syndromes: in vivo and in vitro cytotoxicity

1991 ◽  
Vol 27 (7) ◽  
pp. 842-845 ◽  
Author(s):  
Gerrit J. Ossenkoppele ◽  
Pierre W. Wijermans ◽  
J.J.P. Nauta ◽  
Peter C. Huijgens ◽  
Mart M.A.C. Langenhuijsen
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Myelodysplastic Syndromes ◽  
Low Dose ◽  
In Vitro Cytotoxicity ◽  
Low Dose Cytarabine ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document